Die feline infektiöse Peritonitis – ein Update

Die feline infektiöse Peritonitis (FIP) galt bis vor Kurzem als unheilbar. Hoffnung geben neue antivirale Wirkstoffe, die jedoch nicht zugelassen sind und von Tierärzten in vielen europäischen Ländern nicht angewendet werden dürfen. Viele Katzenbesitzer beziehen Präparate über den Schwarzmarkt in der Hoffnung, ihre Katze damit zu retten.

Publikationsverlauf

Artikel online veröffentlicht:
23. August 2024

• Literatur

• 1 Cave TA, Thompson H, Reid SWJ. et al. Kitten mortality in the United Kingdom: a retrospective analysis of 274 histopathological examinations (1986 to 2000). Vet Rec 2002; 151 (17) 497-501
• 2 Ritz S, Egberink H, Hartmann K. Effect of feline interferon-omega on the survival time and quality of life of cats with feline infectious peritonitis. J Vet Intern Med 2007; 21 (06) 1193-1197
• 3 Lai MM, Cavanagh D. The molecular biology of coronaviruses. Adv Virus Res 1997; 48: 1-100
• 4 Woo PC, Lau SKP, Huang Y. et al. Coronavirus diversity, phylogeny and interspecies jumping. Exp Biol Med (Maywood) 2009; 234 (10) 1117-1127
• 5 Woo PCY, Lau SKP, Lam CSF. et al. Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J Virol 2012; 86 (07) 3995-4008
• 6 Pedersen NC, Boyle JF, Floyd K. Infection studies in kittens, using feline infectious peritonitis virus propagated in cell culture. Am J Vet Res 1981; 42 (03) 363-367
• 7 Pedersen NC, Boyle JF, Floyd K. et al. An enteric coronavirus infection of cats and its relationship to feline infectious peritonitis. Am J Vet Res 1981; 42 (03) 368-377
• 8 Pedersen NC, Black JW, Boyle JF. et al. Pathogenic differences between various feline coronavirus isolates. Adv Exp Med Biol 1984; 173: 365-380
• 9 Addie DD, Jarrett O. A study of naturally occurring feline coronavirus infections in kittens. Vet Rec 1992; 130 (07) 133-137
• 10 Addie DD, Toth S, Murray GD. et al. Risk of feline infectious peritonitis in cats naturally infected with feline coronavirus. Am J Vet Res 1995; 56 (04) 429-434
• 11 Pedersen NC. A review of feline infectious peritonitis virus infection: 1963–2008. J Feline Med Surg 2009; 11 (04) 225-258
• 12 Pedersen NC, Liu H, Dodd KA. et al. Significance of coronavirus mutants in feces and diseased tissues of cats suffering from feline infectious peritonitis. Viruses 2009; 1 (02) 166-184
• 13 Desmarets LM, Vermeulen BL, Theuns S. et al. Experimental feline enteric coronavirus infection reveals an aberrant infection pattern and shedding of mutants with impaired infectivity in enterocyte cultures. Sci Rep 2016; 6: 20022
• 14 Woo PCY, Huang Y, Lau SKP. et al. Coronavirus genomics and bioinformatics analysis. Viruses 2010; 2 (08) 1804-1820
• 15 Poland AM, Vennema H, Foley JE. et al. Two related strains of feline infectious peritonitis virus isolated from immunocompromised cats infected with a feline enteric coronavirus. J Clin Microbiol 1996; 34 (12) 3180-3184
• 16 Vennema H, Poland A, Foley J. et al. Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology 1998; 243 (01) 150-157
• 17 Tasker S, Addie DD, Egberink H. et al. Feline Infectious Peritonitis: European Advisory Board on Cat Diseases Guidelines. Viruses 2023; 15 (09) 1847
• 18 Kipar A, Meli ML. Feline infectious peritonitis: still an enigma?. Vet Pathol 2014; 51 (02) 505-526
• 19 Sparkes AH, Gruffydd-Jones TJ, Harbour DA. Feline infectious peritonitis: a review of clinicopathological changes in 65 cases, and a critical assessment of their diagnostic value. Vet Rec 1991; 129 (10) 209-212
• 20 Tsai HY, Chueh LL, Lin CN. et al. Clinicopathological findings and disease staging of feline infectious peritonitis: 51 cases from 2003 to 2009 in Taiwan. J Feline Med Surg 2011; 13 (02) 74-80
• 21 Riemer F, Kuehner KA, Ritz S. et al. Clinical and laboratory features of cats with feline infectious peritonitis–a retrospective study of 231 confirmed cases (2000–2010). J Feline Med Surg 2016; 18 (04) 348-356
• 22 Kent M. The cat with neurological manifestations of systemic disease. Key conditions impacting on the CNS. J Feline Med Surg 2009; 11 (05) 395-407
• 23 Pedersen NC. An update on feline infectious peritonitis: diagnostics and therapeutics. Vet J 2014; 201 (02) 133-141
• 24 European advisory board on cat diseases (ABCD). FIP diagnosis tool (2023). Im Internet: https://www.abcdcatsvets.org/wp-content/uploads/2023/10/FIP_diagnostic_tool_Sept_2023.pdf Stand: 31.05.2024
• 25 Andrew SE. Feline infectious peritonitis. Vet Clin North Am Small Anim Pract 2000; 30 (05) 987-1000
• 26 Weber S, Holicki C, Krentz D. et al. One to beat them all? Efficacy of a multi-component drug containing GS-441524 against feline coronavirus and SARS-CoV-2. 14th Annual Meeting Epizone, 2022: Barcelona, 18. – 20. Mai.
• 27 Cho A, Saunders OL, Butler T. et al. Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosides. Bioorg Med Chem Lett 2012; 22 (08) 2705-2707
• 28 Murphy BG, Perron M, Murakami E. et al. The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. Vet Microbiol 2018; 219: 226-233
• 29 Amirian ES, Levy JK. Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses. One Health 2020; 9: 100128
• 30 Doki T, Takahashi K, Hasegawa N. et al. In vitro antiviral effects of GS-441524 and itraconazole combination against feline infectious peritonitis virus. Res Vet Sci 2022; 144: 27-33
• 31 Pedersen NC, Perron M, Bannasch M. et al. Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. J Feline Med Surg 2019; 21 (04) 271-281
• 32 Krentz D, Zenger K, Alberer M. et al. Curing cats with feline infectious peritonitis with an oral multi-component drug containing GS-441524. Viruses 2021; 13 (11) 2228
• 33 Jones S, Novicoff W, Nadeau J. et al. Unlicensed GS-441524-like antiviral therapy can be effective for at-home treatment of feline infectious peritonitis. Animals (Basel) 2021; 11 (08) 2257
• 34 Meli ML, Spiri AM, Zwicklbauer K. et al. Fecal feline coronavirus RNA shedding and spike gene mutations in cats with feline infectious peritonitis treated with GS-441524. Viruses 2022; 14 (05) 1069
• 35 Krentz D, Zwicklbauer K, Felten S. et al. Clinical follow-up and postmortem findings in a cat that was cured of feline infectious peritonitis with an oral antiviral drug containing GS-441524. Viruses 2022; 14 (09) 2040
• 36 Zwicklbauer K, Krentz D, Bergmann M. et al. Long-term follow-up of cats in complete remission after treatment of feline infectious peritonitis with oral GS-441524. J Feline Med Surg 2023; 25 (08)
• 37 Zuzzi-Krebitz AM, Buchta K, Bergmann M. et al. Short treatment of 42 days with oral GS-441524 results in equal efficacy as the recommended 84-day treatment in cats suffering from feline infectious peritonitis with effusion – a prospective randomized controlled study. Viruses 2024; 16 (07) 1144
• 38 Attipa C, Warr AS, Epaminondas D. et al. Emergence and spread of feline infectious peritonitis due to a highly pathogenic canine/feline recombinant coronavirus. bioRxiv 2023;